Calian Group Ltd. (TSE:CGY - Get Free Report) declared a quarterly dividend on Tuesday, May 27th, TickerTech Dividends reports. Shareholders of record on Tuesday, June 10th will be given a dividend of 0.28 per share on Tuesday, June 10th. This represents a $1.12 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date of this dividend is Tuesday, May 27th.
Calian Group Stock Down 1.0%
Shares of CGY opened at C$38.52 on Friday. Calian Group has a 52-week low of C$38.20 and a 52-week high of C$57.55. The company has a market capitalization of C$457.27 million, a PE ratio of 41.25, a price-to-earnings-growth ratio of 2.50 and a beta of 0.88. The stock has a fifty day simple moving average of C$44.56 and a two-hundred day simple moving average of C$46.26. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Royal Bank of Canada cut their price objective on shares of Calian Group from C$60.00 to C$58.00 and set an "outperform" rating for the company in a research report on Thursday. Canaccord Genuity Group cut their price target on shares of Calian Group from C$75.00 to C$60.00 and set a "buy" rating for the company in a report on Thursday. Desjardins decreased their price objective on Calian Group from C$82.00 to C$61.00 and set a "buy" rating on the stock in a report on Thursday. Finally, CIBC decreased their target price on shares of Calian Group from C$63.00 to C$62.00 in a research report on Friday, February 14th.
Read Our Latest Stock Analysis on Calian Group
About Calian Group
(
Get Free Report)
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calian Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.
While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
